Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-21-035330)

Filing Details

Accession Number:: 0000899243-21-035330
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-09-08 16:10:08
Reporting Period:: 2021-09-03

Accepted Time:: 2021-09-08 16:10:08
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1661998	Homology Medicines Inc.	FIXX	Pharmaceutical Preparations (2834)	473468154

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1754067	P Timothy Kelly	C/O Homology Medicines, Inc. One Patriots Park Bedford MA 01730	See Remarks.	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-09-03	54	$7.70	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020.
Includes 54 shares acquired under Issuer's Employee Stock Purchase Plan on August 31, 2021.